Back to all News & Insights

Adaptive Phage Therapeutics Announces Collaboration with Mayo Clinic

The NEXT team at Shulman Rogers is proud to have served as counsel to Adaptive Phage Therapeutics, our long-standing client, in establishing an important collaborative relationship with Mayo Clinic Laboratories to commercialize a phage susceptibility test.

To learn more about this exciting partnership, access the press release here.